CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
Grant income	$ 0	$ 35,506
Operating Expenses:
Research and development	5,414,760	4,252,813
General and administrative	3,316,156	2,638,896
Total operating expenses	8,730,916	6,891,709
Operating loss	(8,730,916)	(6,856,203)
Other income	0	18,448
Gain on derivative instruments	932,836	766,509
Other non-operating gains	121,606	790,669
Interest expense, net	(260,390)	(250,783)
Net loss	(7,936,864)	(5,531,360)
Modification of warrants	(85,779)	0
Net loss available to common shareholders	$ (8,022,643)	$ (5,531,360)
Net loss per common share
BASIC	$ (0.21)	$ (0.16)
DILUTED	$ (0.21)	$ (0.16)
Weighted average common shares outstanding
BASIC	38,670,247	35,084,279
DILUTED	38,767,286	35,098,608